CHRISTOPHER JOHN PITTENGER

Summary

Affiliation: Yale University
Country: USA

Publications

  1. pmc Glutamatergic agents for OCD and related disorders
    Christopher Pittenger
    Child Study Center Yale University 34 Park Street, W315 New Haven, CT 06519 203 974 7675 phone 203 974 7805 fax
    Curr Treat Options Psychiatry 2:271-283. 2015
  2. pmc OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding
    Christopher Pittenger
    Department of Psychiatry, Yale University School of Medicine, USA Department of Psychology, Yale University School of Medicine, USA Child Study Center, Yale University School of Medicine, USA Interdepartmental Neuroscience Program, Yale University School of Medicine, USA Electronic address
    J Affect Disord 196:87-96. 2016
  3. pmc Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial
    Christopher Pittenger
    34 Park St, W315, New Haven, CT 06519
    J Clin Psychiatry 76:1075-84. 2015
  4. pmc Pharmacological treatment of obsessive-compulsive disorder
    Christopher Pittenger
    Department of Psychiatry and Child Study Center, Yale University School of Medicine, 34 Park Street, New Haven, CT 06519, USA Electronic address
    Psychiatr Clin North Am 37:375-91. 2014
  5. pmc Microglial dysregulation in psychiatric disease
    Luciana Romina Frick
    Department of Psychiatry, Yale University School of Medicine, 34 Park Street, W315, New Haven, CT 06519, USA
    Clin Dev Immunol 2013:608654. 2013
  6. pmc Disorders of memory and plasticity in psychiatric disease
    Christopher Pittenger
    Yale OCD Research Clinic, Yale University School of Medicine, New Haven, Connecticut, USA
    Dialogues Clin Neurosci 15:455-63. 2013
  7. pmc Lesions of the dorsomedial striatum delay spatial learning and render cue-based navigation inflexible in a water maze task in mice
    Anni S Lee
    Department of Psychiatry, Yale University New Haven, CT, USA Weill Cornell Graduate School New York, NY, USA
    Front Behav Neurosci 8:42. 2014
  8. ncbi request reprint Riluzole in the treatment of mood and anxiety disorders
    Christopher Pittenger
    Clinical Neuroscience Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA
    CNS Drugs 22:761-86. 2008
  9. pmc Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment
    Christopher Pittenger
    Department of Psychiatry, Yale University School of Medicine, USA
    Pharmacol Ther 132:314-32. 2011

Collaborators

Detail Information

Publications9

  1. pmc Glutamatergic agents for OCD and related disorders
    Christopher Pittenger
    Child Study Center Yale University 34 Park Street, W315 New Haven, CT 06519 203 974 7675 phone 203 974 7805 fax
    Curr Treat Options Psychiatry 2:271-283. 2015
    ....
  2. pmc OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding
    Christopher Pittenger
    Department of Psychiatry, Yale University School of Medicine, USA Department of Psychology, Yale University School of Medicine, USA Child Study Center, Yale University School of Medicine, USA Interdepartmental Neuroscience Program, Yale University School of Medicine, USA Electronic address
    J Affect Disord 196:87-96. 2016
    ..Differential associations of 5-HT1B receptor availability with PPI in patients suggest functionally important alterations in the serotonergic regulation of cortical/subcortical balance in OCD. ..
  3. pmc Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial
    Christopher Pittenger
    34 Park St, W315, New Haven, CT 06519
    J Clin Psychiatry 76:1075-84. 2015
    ..We report a pilot randomized placebo-controlled trial of riluzole augmentation of ongoing SRI treatment in SRI-refractory patients...
  4. pmc Pharmacological treatment of obsessive-compulsive disorder
    Christopher Pittenger
    Department of Psychiatry and Child Study Center, Yale University School of Medicine, 34 Park Street, New Haven, CT 06519, USA Electronic address
    Psychiatr Clin North Am 37:375-91. 2014
    ..Proven second-line treatments include the tricyclic clomipramine and the addition of low-dose neuroleptic medications. OCD refractory to available treatments remains a profound clinical challenge. ..
  5. pmc Microglial dysregulation in psychiatric disease
    Luciana Romina Frick
    Department of Psychiatry, Yale University School of Medicine, 34 Park Street, W315, New Haven, CT 06519, USA
    Clin Dev Immunol 2013:608654. 2013
    ..If microglial pathology proves to be an important causative factor in these or other neuropsychiatric diseases, modulators of microglial function may represent a novel therapeutic strategy...
  6. pmc Disorders of memory and plasticity in psychiatric disease
    Christopher Pittenger
    Yale OCD Research Clinic, Yale University School of Medicine, New Haven, Connecticut, USA
    Dialogues Clin Neurosci 15:455-63. 2013
    ....
  7. pmc Lesions of the dorsomedial striatum delay spatial learning and render cue-based navigation inflexible in a water maze task in mice
    Anni S Lee
    Department of Psychiatry, Yale University New Haven, CT, USA Weill Cornell Graduate School New York, NY, USA
    Front Behav Neurosci 8:42. 2014
    ..After cued learning, lesioned animals showed inflexible search, resulting in repeated visits to the escape platform-associated cue. These results support a role for the DMS in behavioral flexibility rather than in cue-based navigation...
  8. ncbi request reprint Riluzole in the treatment of mood and anxiety disorders
    Christopher Pittenger
    Clinical Neuroscience Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA
    CNS Drugs 22:761-86. 2008
    ..Riluzole may hold promise for the treatment of several psychiatric conditions, possibly through its ability to modulate pathologically dysregulated glutamate levels, and merits further investigation...
  9. pmc Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment
    Christopher Pittenger
    Department of Psychiatry, Yale University School of Medicine, USA
    Pharmacol Ther 132:314-32. 2011
    ....